University of Leeds:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of Leeds - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9325
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Leeds (University of Leeds) is an educational university that offers academic programs. The university offers undergraduate, post graduate, research degrees, online and distance learning educational programs. It offers education programs in the areas of arts, biological sciences, business, education, social sciences and law; engineering, environment, mathematics and physical sciences; medicine and health; performance, visual arts, communications, and others. University of Leeds also offers funding and scholarships. It also conducts research across various disciplines. The university provides services such as accommodation, online library, students union and other society membership facilities. University of Leeds is headquartered in Leeds, the UK.

University of Leeds – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Leeds, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Leeds, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Leeds, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Leeds, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Leeds, Medical Devices Deals, 2012 to YTD 2018 9
University of Leeds, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
University of Leeds, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Censo Biotech Partners with University of Leeds 11
Arix Bioscience, Lead Discovery Center, Max Planck Innovation and University of Leeds Enter into Partnership 12
Avacta Enters into Research Agreement with University of Leeds 13
iQur Enters into Co-Development Agreement with Six Consortium 14
University of Leeds – Key Competitors 15
University of Leeds – Key Employees 16
University of Leeds – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
Oct 03, 2018: Leeds researcher secures new funding to explore treatments for damaged hearts 18
Feb 01, 2017: Scientists prove new approach to Polio vaccines works 19
Other Significant Developments 21
Sep 13, 2018: Viruses show new promise in treating cancer 21
Jan 12, 2018: More than £2.2m awarded to Leeds researchers to tackle cancer 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
University of Leeds, Pharmaceuticals & Healthcare, Key Facts 2
University of Leeds, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Leeds, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Leeds, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Leeds, Deals By Therapy Area, 2012 to YTD 2018 8
University of Leeds, Medical Devices Deals, 2012 to YTD 2018 9
University of Leeds, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Censo Biotech Partners with University of Leeds 11
Arix Bioscience, Lead Discovery Center, Max Planck Innovation and University of Leeds Enter into Partnership 12
Avacta Enters into Research Agreement with University of Leeds 13
iQur Enters into Co-Development Agreement with Six Consortium 14
University of Leeds, Key Competitors 15
University of Leeds, Key Employees 16
University of Leeds, Subsidiaries 17

List of Figures
University of Leeds, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Leeds, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Leeds, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Leeds, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Leeds, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Leeds, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of Leeds, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Leeds, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Leeds, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[University of Leeds:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IXYS Corporation (IXYS):企業の財務・戦略的SWOT分析
    IXYS Corporation (IXYS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Petroleum Development Oman LLC:企業の戦略的SWOT分析
    Petroleum Development Oman LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Arthrex Inc-医療機器分野:企業M&A・提携分析
    Summary Arthrex Inc (Arthrex), formerly, Arthroscopy Excision Instruments Inc., is a medical device company which designs, and manufactures surgical products and solutions used for arthroscopic and minimally invasive orthopedic surgical procedures. The company offers shoulder, knee, elbow, hand and …
  • Niko Resources Ltd (NKO):石油・ガス:M&Aディール及び事業提携情報
    Summary Niko Resources Ltd (Niko Resources) is an independent oil and gas exploration and production company that acquires, explores, develops and produces crude oil and natural gas properties. The company concentrates on value generation in the D6 Block in India. It offers financing options for the …
  • Myriad Genetics, Inc.:企業の戦略・SWOT・財務分析
    Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Evofem Inc-医療機器分野:企業M&A・提携分析
    Summary Evofem Inc (Evofem) is a healthcare solution provider that discovers, develops and commercializes prescription and consumer products. The company’s product pipeline includes amphora and nestorone. Evofem improves reproductive health and wellness options for women. It develops products for co …
  • Kansas Electric Power Cooperative Inc:企業の戦略的SWOT分析
    Kansas Electric Power Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Damac Real Estate Development Ltd:企業の戦略・SWOT・財務分析
    Damac Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report Summary Damac Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Close Brothers Asset Management:企業の戦略・SWOT・財務情報
    Close Brothers Asset Management - Strategy, SWOT and Corporate Finance Report Summary Close Brothers Asset Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Societe Generale S.A.:企業の戦略・SWOT・財務情報
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SKC Co., Ltd. (011790):企業の財務・戦略的SWOT分析
    SKC Co., Ltd. (011790) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • H. Lundbeck AS (LUN):製薬・医療:M&Aディール及び事業提携情報
    Summary H. Lundbeck AS (Lundbeck), a subsidiary of The Lundbeck Foundation, carries out the research, development, manufacturing and marketing of pharmaceuticals for the treatment of the central nervous system (CNS) diseases including psychiatric and neurological disorders. Its products are indicate …
  • Jouve SA:企業の戦略的SWOT分析
    Jouve SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Johnson & Johnson (JNJ):医療機器:M&Aディール及び事業提携情報
    Summary Johnson & Johnson (J&J) researches and develops, and manufactures and sells a range of pharmaceutical products, medical devices and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular and metabolic diseases; …
  • Electricity Supply Board:発電所・企業SWOT分析
    Electricity Supply Board - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Biomatrica Inc:医療機器:M&Aディール及び事業提携情報
    Summary Biomatrica Inc (Biomatrica) is a developer, manufacturer, and supplier of stability technologies preserve biological materials. The company offers DNA, RNA, proteins, cells, and entire assays for diagnostics, research, forensics, biobanks, and sustainability applications. Its products includ …
  • Bulgarian Energy Holding EAD:企業の戦略的SWOT分析
    Bulgarian Energy Holding EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • DiamondRock Hospitality Co:戦略・SWOT・企業財務分析
    DiamondRock Hospitality Co - Strategy, SWOT and Corporate Finance Report Summary DiamondRock Hospitality Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Hobby Lobby Stores Inc:企業の戦略・SWOT・財務情報
    Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cellmid Ltd (CDY):企業の財務・戦略的SWOT分析
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆